Fig. 3
From: Maraviroc/cisplatin combination inhibits gastric cancer tumoroid growth and improves mice survival
Cell cycle analysis of AGS R-CDDP cells exposed to MVC and/or CDDP. Cells were incubated with MVC and/or CDDP for (A) 24, (B) 48, and (C) 72 h by flow cytometry. Two-way ANOVA with Bonferroni post-hoc test was used to compare the groups. Data were expressed as mean ± SD of three biological replicates. Maraviroc (MVC) and Cisplatin (CDDP)